Friday, October 4, 2019

Lupin launches generic immunosuppressant capsules in US

Lupin launches generic immunosuppressant capsules in US As per IQVIA MAT August 2019 data, Mycophenolate Mofetil capsules USP, 250 mg, had annual sales of around $ 53 million in the US, Lupin said.

from Moneycontrol Business News https://ift.tt/30ETMsM

No comments:

Post a Comment

FII exodus deepens in 2026 at Rs 1.75 lakh crore as April outflows swell to Rs 43,967 crore; FOMC next trigger

Foreign institutional investors offloaded Indian equities worth Rs 17,140 crore last week, extending April's outflows to Rs 43,967 crore...